Search results for: Health Data and Statistics

Phill O’Neill

22 May 2014

Phill Phill O’Neill has over 25 years’ experience in the use of pharmaceutical industry data and information. His research interests include the economics of the pharmaceutical market, the productivity, and…

Cancer Survivorship Burden

6 March 2018

…care Healthcare system / insurer Out of pocket (OOP) costs Survivor (and family) Indirect Costs Productivity loss Survivor (and family); Caregivers Informal caregiving cost Caregivers Health-related quality of life (HRQoL)…

New Research by OHE and University of Glasgow on cost of QALYs in Scotland

17 December 2012

…American Pharma Group. Scotland is divided into 14 geographical NHS Boards that are responsible for both the commissioning and provision of health services. In 2010 and 2012, each NHS Board…

Insights and Reflections from 2023

31 January 2024, 3:00pm

…and recommendations from our recently published prevention whitepaper Sustainability: Spotlighting our work focussing on sustainability throughout 2023 Innovative Outcome Measures Key Policy Reforms:  Implementation of IRA in the US and EU…

David Mott

14 August 2019

…modifier, integrating carer spillovers into health technology assessment, eliciting treatment and health outcome preferences of people with acute and chronic leukaemia, and exploring the complexities of valuing health in children…

Matthias Hofer

5 April 2023

…of health technologies, the dynamics of pharmaceutical markets and innovation, and the economic impact of policy and technological change. Before joining OHE, Matthias worked at Imperial College Business School conducting…

Our governance and network

Our Board of Trustees and advisory committees are essential to guiding our work, maintaining the quality and independence of our research programme and our publications, and ensuring we align with…

OHE Lunchtime Seminar on 29 April 2015: Do Financial Incentives Trump Clinical Guidance? Hip Replacement in England and Scotland

24 March 2015

…are focused on performance measurement, international comparisons of health systems and performance based payment systems.   Professor Alistair McGuire is a Professor in Health Economics at LSE Health and Social…

HTA in Japan: Failing to Meet International Good Practice?

15 March 2019

…contextualisation; and (iv) implementation and monitoring. Assessment in Japan follows a standard methods approach and the premium adjustment to the Japanese price does not have much impact on product use…